{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:14:41Z","timestamp":1776057281828,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00204-013-1147-9","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T03:50:52Z","timestamp":1383191452000},"page":"515-531","source":"Crossref","is-referenced-by-count":31,"title":["\"Ecstasy\"-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites"],"prefix":"10.1007","volume":"88","author":[{"given":"Daniel Jos\u00e9","family":"Barbosa","sequence":"first","affiliation":[]},{"given":"Jo\u00e3o Paulo","family":"Capela","sequence":"additional","affiliation":[]},{"given":"Renata","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa Maria","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Paula S\u00e9rio","family":"Branco","sequence":"additional","affiliation":[]},{"given":"Eduarda","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Maria Lourdes","family":"Bastos","sequence":"additional","affiliation":[]},{"given":"F\u00e9lix","family":"Carvalho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,11,1]]},"reference":[{"key":"1147_CR1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/cne.20994","volume":"497","author":"C \u00c1dori","year":"2006","unstructured":"\u00c1dori C, And\u00f3 RD, Kov\u00e1cs GG, Bagdy G (2006) Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns. J Comp Neurol 497:251\u2013269","journal-title":"J Comp Neurol"},{"key":"1147_CR2","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1152\/ajpcell.00620.2006","volume":"292","author":"P Aguirre","year":"2007","unstructured":"Aguirre P, Vald\u00e9s P, Aracena-Parks P, Tapia V, N\u00fa\u00f1ez MT (2007) Upregulation of \u03b3-glutamate-cysteine ligase as part of the long-term adaptation process to iron accumulation in neuronal SH-SY5Y cells. Am J Physiol Cell Physiol 292:2197\u20132203","journal-title":"Am J Physiol Cell Physiol"},{"key":"1147_CR3","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1021\/tx990084t","volume":"12","author":"F Bai","year":"1999","unstructured":"Bai F, Lau SS, Monks TJ (1999) Glutathione and N-acetylcysteine conjugates of \u03b1-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity. Chem Res Toxicol 12:1150\u20131157","journal-title":"Chem Res Toxicol"},{"key":"1147_CR4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/tx010011l","volume":"14","author":"F Bai","year":"2001","unstructured":"Bai F, Jones DC, Lau SS, Monks TJ (2001) Serotonergic neurotoxicity of 3,4-(\u00b1)-methylenedioxyamphetamine and 3,4-(\u00b1)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of \u03b3-glutamyl transpeptidase. Chem Res Toxicol 14:863\u2013870","journal-title":"Chem Res Toxicol"},{"key":"1147_CR5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mam.2008.08.004","volume":"30","author":"N Ballatori","year":"2009","unstructured":"Ballatori N, Krance SM, Marchan R, Hammond CL (2009) Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology. Mol Aspects Med 30:13\u201328","journal-title":"Mol Aspects Med"},{"key":"1147_CR6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1476-5381.2011.01453.x","volume":"165","author":"DJ Barbosa","year":"2012","unstructured":"Barbosa DJ, Capela JP, Oliveira JMA et al (2012) Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes. Br J Pharmacol 165:1017\u20131033","journal-title":"Br J Pharmacol"},{"key":"1147_CR150","doi-asserted-by":"crossref","unstructured":"Barbosa DJ, Capela JP, Silva R et al (2013) The mixture of \u201cecstasy\u201d and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations. Arch Toxicol. doi: 10.1007\/s00204-013-1120-7","DOI":"10.1007\/s00204-013-1120-7"},{"key":"1147_CR7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1478-3231.1999.tb00041.x","volume":"19","author":"G Beitia","year":"1999","unstructured":"Beitia G, Cobreros A, Sainz L, Cenarruzabeitia E (1999) 3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: effect on cytosolic calcium signals in isolated hepatocytes. Liver 19:234\u2013241","journal-title":"Liver"},{"key":"1147_CR8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.105.092577","volume":"316","author":"JP Capela","year":"2006","unstructured":"Capela JP, Meisel A, Abreu AR et al (2006a) Neurotoxicity of ecstasy metabolites in rat cortical neurons, and influence of hyperthermia. J Pharmacol Exp Ther 316:53\u201361","journal-title":"J Pharmacol Exp Ther"},{"key":"1147_CR9","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neuroscience.2006.01.007","volume":"139","author":"JP Capela","year":"2006","unstructured":"Capela JP, Ruscher K, Lautenschlager M et al (2006b) Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia. Neuroscience 139:1069\u20131081","journal-title":"Neuroscience"},{"key":"1147_CR10","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.neuroscience.2007.03.028","volume":"146","author":"JP Capela","year":"2007","unstructured":"Capela JP, Macedo C, Branco PS et al (2007) Neurotoxicity mechanisms of thioether ecstasy metabolites. Neuroscience 146:1743\u20131757","journal-title":"Neuroscience"},{"key":"1147_CR11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12035-009-8064-1","volume":"39","author":"JP Capela","year":"2009","unstructured":"Capela JP, Carmo H, Remi\u00e3o F, Bastos ML, Meisel A, Carvalho F (2009) Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol 39:210\u2013271","journal-title":"Mol Neurobiol"},{"key":"1147_CR12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s002040000200","volume":"74","author":"M Carvalho","year":"2001","unstructured":"Carvalho M, Carvalho F, Bastos ML (2001) Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes. Arch Toxicol 74:789\u2013793","journal-title":"Arch Toxicol"},{"key":"1147_CR13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00204-002-0381-3","volume":"76","author":"M Carvalho","year":"2002","unstructured":"Carvalho M, Hawksworth G, Milhazes N et al (2002) Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells. Arch Toxicol 76:581\u2013588","journal-title":"Arch Toxicol"},{"key":"1147_CR14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tox.2004.03.016","volume":"200","author":"M Carvalho","year":"2004","unstructured":"Carvalho M, Remiao F, Milhazes N et al (2004a) The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine. Toxicology 200:193\u2013203","journal-title":"Toxicology"},{"key":"1147_CR15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/tx049960f","volume":"17","author":"M Carvalho","year":"2004","unstructured":"Carvalho M, Remi\u00e3o F, Milhazes N et al (2004b) Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro. Chem Res Toxicol 17:623\u2013632","journal-title":"Chem Res Toxicol"},{"key":"1147_CR16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00204-012-0815-5","volume":"86","author":"M Carvalho","year":"2012","unstructured":"Carvalho M, Carmo H, Costa VM et al (2012) Toxicity of amphetamines: an update. Arch Toxicol 86:1167\u20131231","journal-title":"Arch Toxicol"},{"key":"1147_CR17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/014107689108400622","volume":"84","author":"IS Chadwick","year":"2001","unstructured":"Chadwick IS, Curry PD, Linsley A, Freemont AJ, Doran B (2001) Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. J R Soc Med 84:371","journal-title":"J R Soc Med"},{"key":"1147_CR18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0006-2952(95)02397-6","volume":"51","author":"T Chu","year":"1996","unstructured":"Chu T, Kumagai Y, DiStefano EW, Cho AK (1996) Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Biochem Pharmacol 51:789\u2013796","journal-title":"Biochem Pharmacol"},{"key":"1147_CR19","first-page":"338","volume":"241","author":"DL Commins","year":"1987","unstructured":"Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS (1987) Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241:338\u2013345","journal-title":"J Pharmacol Exp Ther"},{"key":"1147_CR20","doi-asserted-by":"crossref","unstructured":"Constantinescu R, Constantinescu AT, Reichmann H, Janetzky B (2007) Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y. J Neural Transm (Suppl 72):17\u201328","DOI":"10.1007\/978-3-211-73574-9_3"},{"key":"1147_CR21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tips.2004.08.001","volume":"25","author":"R Torre de la","year":"2004","unstructured":"de la Torre R, Farr\u00e9 M (2004) Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans. Trends Pharmacol Sci 25:505\u2013508","journal-title":"Trends Pharmacol Sci"},{"key":"1147_CR22","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1476-5381.2010.00722.x","volume":"160","author":"JR Docherty","year":"2010","unstructured":"Docherty JR, Green AR (2010) The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives. Br J Pharmacol 160:1029\u20131044","journal-title":"Br J Pharmacol"},{"key":"1147_CR23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1124\/jpet.107.128785","volume":"324","author":"GV Erives","year":"2008","unstructured":"Erives GV, Lau SS, Monks TJ (2008) Accumulation of neurotoxic thioether metabolites of 3,4-(\u00b1)-methylenedioxymethamphetamine in rat brain. J Pharmacol Exp Ther 324:284\u2013291","journal-title":"J Pharmacol Exp Ther"},{"key":"1147_CR24","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1001\/archgenpsychiatry.2011.56","volume":"68","author":"D Erritzoe","year":"2011","unstructured":"Erritzoe D, Frokjaer VG, Holst KK et al (2011) In vivo imaging of cerebral serotonin transporter and serotonin2a receptor binding in 3,4-methylenedioxymethamphetamine (mdma or \u201cecstasy\u201d) and hallucinogen users. Arch Gen Psychiatry 68:562\u2013576","journal-title":"Arch Gen Psychiatry"},{"key":"1147_CR25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjp.0706071","volume":"144","author":"I Escobedo","year":"2005","unstructured":"Escobedo I, O\u2019Shea E, Orio L et al (2005) A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice. Br J Pharmacol 144:231\u2013241","journal-title":"Br J Pharmacol"},{"key":"1147_CR26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002130000645","volume":"154","author":"B Esteban","year":"2001","unstructured":"Esteban B, O\u2019Shea E, Camarero J, Sanchez V, Green AR, Colado MI (2001) 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology 154:251\u2013260","journal-title":"Psychopharmacology"},{"key":"1147_CR27","first-page":"860","volume":"272","author":"GM Farfel","year":"1995","unstructured":"Farfel GM, Seiden LS (1995) Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. J Pharmacol Exp Ther 272:860\u2013867","journal-title":"J Pharmacol Exp Ther"},{"key":"1147_CR28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/tx9003374","volume":"23","author":"A Felim","year":"2009","unstructured":"Felim A, Herrera G, Neud\u00f6rffer A, Blanco M, O\u2019Connor J, Largeron M (2009) Synthesis and in vitro cytotoxicity profile of the R-enantiomer of 3,4-dihydroxymethamphetamine (R-(\u2212)-HHMA): comparison with related catecholamines. Chem Res Toxicol 23:211\u2013219","journal-title":"Chem Res Toxicol"},{"key":"1147_CR29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.toxlet.2012.11.015","volume":"216","author":"PS Ferreira","year":"2013","unstructured":"Ferreira PS, Nogueira TB, Costa VM et al (2013) Neurotoxicity of \u201cecstasy\u201d and its metabolites in human dopaminergic differentiated SH-SY5Y cells. Toxicol Lett 216:159\u2013170","journal-title":"Toxicol Lett"},{"key":"1147_CR30","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1073\/pnas.89.7.3070","volume":"89","author":"AK Godwin","year":"1992","unstructured":"Godwin AK, Meister A, O\u2019Dwyer PJ, Huang CS, Hamilton TC, Anderson ME (1992) High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89:3070\u20133074","journal-title":"Proc Natl Acad Sci USA"},{"key":"1147_CR31","first-page":"455","volume":"10","author":"R Gollamudi","year":"1989","unstructured":"Gollamudi R, Ali SF, Lipe G et al (1989) Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA. Neurotoxicology 10:455\u2013466","journal-title":"Neurotoxicology"},{"key":"1147_CR32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nbd.2011.01.033","volume":"42","author":"N Granado","year":"2011","unstructured":"Granado N, Ares-Santos S, Oliva I et al (2011) Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Neurobiol Dis 42:391\u2013403","journal-title":"Neurobiol Dis"},{"key":"1147_CR33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","volume":"55","author":"AR Green","year":"2003","unstructured":"Green AR, Mechan AO, Elliott JM, O\u2019Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d). Pharmacol Rev 55:463\u2013508","journal-title":"Pharmacol Rev"},{"key":"1147_CR34","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1523\/JNEUROSCI.19-12-05096.1999","volume":"19","author":"G Hatzidimitriou","year":"1999","unstructured":"Hatzidimitriou G, McCann UD, Ricaurte GA (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (\u00b1)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19:5096\u20135107","journal-title":"J Neurosci"},{"key":"1147_CR35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0140-6736(92)91469-O","volume":"340","author":"JA Henry","year":"1992","unstructured":"Henry JA, Jeffreys KJ, Dawling S (1992) Toxicity and deaths from 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d). Lancet 340:384\u2013387","journal-title":"Lancet"},{"key":"1147_CR36","first-page":"521","volume":"254","author":"M Hiramatsu","year":"1990","unstructured":"Hiramatsu M, Kumagai Y, Unger SE, Cho AK (1990) Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. J Pharmacol Exp Ther 254:521\u2013527","journal-title":"J Pharmacol Exp Ther"},{"key":"1147_CR37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/jpet.110.171322","volume":"335","author":"BN Johnson","year":"2010","unstructured":"Johnson BN, Yamamoto BK (2010) Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature. J Pharmacol Exp Ther 335:180\u2013189","journal-title":"J Pharmacol Exp Ther"},{"key":"1147_CR38","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1124\/jpet.104.077628","volume":"313","author":"DC Jones","year":"2005","unstructured":"Jones DC, Duvauchelle C, Ikegami A et al (2005) Serotonergic neurotoxic metabolites of ecstasy identified in rat brain. J Pharmacol Exp Ther 313:422\u2013431","journal-title":"J Pharmacol Exp Ther"},{"key":"1147_CR39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0269881108097724","volume":"24","author":"SJ Kish","year":"2010","unstructured":"Kish SJ, Fitzmaurice PS, Chang LJ, Furukawa Y, Tong J (2010a) Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study. J Psychopharmacol 24:281\u2013284","journal-title":"J Psychopharmacol"},{"key":"1147_CR40","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/brain\/awq103","volume":"133","author":"SJ Kish","year":"2010","unstructured":"Kish SJ, Lerch J, Furukawa Y et al (2010b) Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography\/[11C]DASB and structural brain imaging study. Brain 133:1779\u20131797","journal-title":"Brain"},{"key":"1147_CR41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"1147_CR42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1248\/jhs.53.31","volume":"53","author":"C Macedo","year":"2007","unstructured":"Macedo C, Branco PS, Ferreira LM et al (2007) Synthesis and cyclic voltammetry studies of 3,4-methylenedioxymethamphetamine (MDMA) human metabolites. J Health Sci 53:31\u201342","journal-title":"J Health Sci"},{"key":"1147_CR43","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1523\/JNEUROSCI.18-13-05086.1998","volume":"18","author":"JE Malberg","year":"1998","unstructured":"Malberg JE, Seiden LS (1998) Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18:5086\u20135094","journal-title":"J Neurosci"},{"key":"1147_CR44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/npp.1994.15","volume":"10","author":"UD McCann","year":"1994","unstructured":"McCann UD, Ridenour A, Shaham Y, Ricaurte GA (1994) Serotonin neurotoxicity after (\u00b1)3,4-methylenedioxymethamphetamine (MDMA; \u201cEcstasy\u201d): a controlled study in humans. Neuropsychopharmacology 10:129\u2013138","journal-title":"Neuropsychopharmacology"},{"key":"1147_CR45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1021\/tx9501546","volume":"9","author":"RT Miller","year":"1996","unstructured":"Miller RT, Lau SS, Monks TJ (1996) Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-\u03b1-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats. Chem Res Toxicol 9:457\u2013465","journal-title":"Chem Res Toxicol"},{"key":"1147_CR46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00007691-200404000-00008","volume":"26","author":"TJ Monks","year":"2004","unstructured":"Monks TJ, Jones DC, Fengju B, Lau SS (2004) The role of metabolism in 3,4-Methylenodioxyamphetamine and 3,4-Methylenodioxymethamphetamine (Ecstasy) toxicity. Ther Drug Monit 26:132\u2013136","journal-title":"Ther Drug Monit"},{"key":"1147_CR47","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.freeradbiomed.2004.06.005","volume":"37","author":"MT N\u00fa\u00f1ez","year":"2004","unstructured":"N\u00fa\u00f1ez MT, Gallardo V, Mu\u00f1oz P et al (2004) Progressive iron accumulation induces a biphasic change in the glutathione content of neuroblastoma cells. Free Radic Biol Med 37:953\u2013960","journal-title":"Free Radic Biol Med"},{"key":"1147_CR48","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1476-5381.2012.01941.x","volume":"166","author":"AC Parrott","year":"2012","unstructured":"Parrott AC (2012) MDMA and 5-HT neurotoxicity: the empirical evidence for its adverse effects in humans\u2014no need for translation. Br J Pharmacol 166:1518\u20131520","journal-title":"Br J Pharmacol"},{"key":"1147_CR49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0169-328X(93)90072-W","volume":"17","author":"NJ Patel","year":"1993","unstructured":"Patel NJ, Fullone JS, Anders MW (1993) Brain uptake of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine, the glutathione and cysteine S-conjugates of the neurotoxin dichloroacetylene. Brain Res Mol Brain Res 17:53\u201358","journal-title":"Brain Res Mol Brain Res"},{"key":"1147_CR50","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF03033178","volume":"5","author":"S Presgraves","year":"2003","unstructured":"Presgraves S, Ahmed T, Borwege S, Joyce J (2003) Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox Res 5:579\u2013598","journal-title":"Neurotox Res"},{"key":"1147_CR51","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/0269881106061200","volume":"20","author":"BB Quednow","year":"2006","unstructured":"Quednow BB, Jessen F, K\u00fchn K, Maier W, Daum I, Wagner M (2006) Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction. J Psychopharmacol 20:373\u2013384","journal-title":"J Psychopharmacol"},{"key":"1147_CR52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0006-8993(88)91309-1","volume":"446","author":"GA Ricaurte","year":"1988","unstructured":"Ricaurte GA, DeLanney LE, Irwin I, Langston JW (1988) Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res 446:165\u2013168","journal-title":"Brain Res"},{"key":"1147_CR53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainres.2009.07.040","volume":"1292","author":"GMP Roberts","year":"2009","unstructured":"Roberts GMP, Nestor L, Garavan H (2009) Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task. Brain Res 1292:71\u201381","journal-title":"Brain Res"},{"key":"1147_CR54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0006-8993(03)02563-0","volume":"974","author":"LC Schmued","year":"2003","unstructured":"Schmued LC (2003) Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA. Brain Res 974:127\u2013133","journal-title":"Brain Res"},{"key":"1147_CR55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12012-009-9034-6","volume":"9","author":"SK Shenouda","year":"2009","unstructured":"Shenouda SK, Varner KJ, Carvalho F, Lucchesi PA (2009) Metabolites of MDMA induce oxidative stress and contractile dysfunction in adult rat left ventricular myocytes. Cardiovasc Toxicol 9:30\u201338","journal-title":"Cardiovasc Toxicol"},{"key":"1147_CR56","doi-asserted-by":"crossref","first-page":"26512","DOI":"10.1016\/S0021-9258(18)47224-9","volume":"269","author":"MM Shi","year":"1994","unstructured":"Shi MM, Kugelman A, Iwamoto T, Tian L, Forman HJ (1994) Quinone-induced oxidative stress elevates glutathione and induces gamma-glutamylcysteine synthetase activity in rat lung epithelial L2 cells. J Biol Chem 269:26512\u201326517","journal-title":"J Biol Chem"},{"key":"1147_CR57","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/bmc.796","volume":"21","author":"R Silva","year":"2007","unstructured":"Silva R, Boldt S, Costa VM et al (2007) Evaluation of GSH adducts of adrenaline in biological samples. Biomed Chromatogr 21:670\u2013679","journal-title":"Biomed Chromatogr"},{"key":"1147_CR59","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1124\/dmd.107.019661","volume":"36","author":"AJ Slot","year":"2008","unstructured":"Slot AJ, Wise DD, Deeley RG, Monks TJ, Cole SPC (2008) Modulation of human multidrug resistance protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites. Drug Metab Dispos 36:552\u2013560","journal-title":"Drug Metab Dispos"},{"key":"1147_CR60","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/npp.2010.201","volume":"36","author":"YF Tai","year":"2011","unstructured":"Tai YF, Hoshi R, Brignell CM et al (2011) Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA (\u201cEcstasy\u201d): an 18F-dopa PET study. Neuropsychopharmacology 36:735\u2013743","journal-title":"Neuropsychopharmacology"},{"key":"1147_CR61","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jnr.21869","volume":"87","author":"H Takeuchi","year":"2009","unstructured":"Takeuchi H, Yanagida T, Inden M et al (2009) Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson\u2019s disease models. J Neurosci Res 87:576\u2013585","journal-title":"J Neurosci Res"},{"key":"1147_CR62","doi-asserted-by":"crossref","first-page":"e9143","DOI":"10.1371\/journal.pone.0009143","volume":"5","author":"C Touri\u00f1o","year":"2010","unstructured":"Touri\u00f1o C, Zimmer A, Valverde O (2010) THC prevents MDMA neurotoxicity in mice. PLoS ONE 5:e9143","journal-title":"PLoS ONE"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-013-1147-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-013-1147-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-013-1147-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T04:49:27Z","timestamp":1646974167000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-013-1147-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,1]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1007\/s00204-013-1147-9","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,1]]}}}